Eukaryotic cell media
TW202637831APending Publication Date: 2026-09-16GENENTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114146003
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-06-23
- Filing Date
- 2025-11-25
- Publication Date
- 2026-09-16
Smart Images

Figure TWG2TA001076522_001 
Figure TWG2TA001076522_002 
Figure TWG2TA001076522_003
Abstract
This disclosure relates to eukaryotic cell culture media useful in the production of recombinant proteins from cultured cell lines. The eukaryotic cell culture media comprise integrated stress response inhibitor (ISRIB), and / or hypotaurine and / or increased level of iron, and / or suramin. The disclosure also provides methods using said eukaryotic cell culture media, e.g. for culturing mammalian cells with enhanced product titer, and / or growth,and / or viability and / or for producing a recombinant protein of comparable or better product quality by culturing a eukaryotic cell line that comprises a polynucleotide encoding the recombinant protein in said media under conditions suitable for production of the polypeptide. Also provided are use of the eukaryotic cell culture media for the production of a recombinant protein from a cultured cell line comprising a polynucleotide encoding the recombinant protein.
Need to check novelty before this filing date? Find Prior Art
